Survey Shows High Level of Parental Hesitancy for COVID-19 Vaccines
The survey asked about the likelihood of both child and parental vaccination, perceptions about the vaccines and the level of trust in various sources of information.
Diagnosis & Disease Information
Lower Dose COVID-19 Vaccine Appears Safe, Immunogenic in Children 5 to 11 Years Old
Participants 5 to 11 years of age received a 2-dose regimen of 10mcg administered 21 days apart.
Comparison of Hospital Treatment of Alpha vs Delta COVID-19 Variants
Researchers sought to compare the risk for hospital and emergency department admission for the treatment of COVID-19 among patients infected with the Alpha variant vs those with the Delta variant.
Moderna Submits COVID-19 Vaccine Booster Data for FDA Review
A single 50µg dose of mRNA-1273 given as a booster increased neutralizing antibody titer responses above the phase 3 benchmark.
Responses to COVID-19 Vaccines in Cancer Patients: Impact of Tumor and Treatment Type
Most patients with solid tumors demonstrate immune responses to COVID-19 vaccines, but a subset of patients do not.
Experts Disagree on COVID-19 Vaccine Mandates for Health Care Providers
Experts outline benefits and detriments of COVID-19 vaccine mandates.
Pfizer, BioNTech Submit Supplemental BLA for COVID-19 Vaccine Booster
The application includes data from a phase 3 trial that evaluated a booster dose of Comirnaty in 306 adult participants 18 to 55 years of age who were previously vaccinated with a 2-dose primary regimen.
Biologics License Application for Moderna COVID-19 Vaccine Submitted to FDA
The application includes data from the phase 3 COVE study that evaluated the Moderna COVID-19 vaccine in 30,420 adults 18 years of age and older.
ACOG Releases Updated COVID-19 Vaccine Recommendations for Obstetric-Gynecologic Care
The American College of Obstetricians and Gynecologists (ACOG) strongly recommends that all eligible individuals, including those who are pregnant, recently pregnant, and lactating, receive a COVID-19 vaccine.
Responses to COVID-19 Vaccines Vary in Patients With Hematologic Malignancies
Responses varied according to patients’ cancer type, the anticancer treatment they received, and which vaccine was used.
- Loading...
Loading...
Loading... 
Loading...